Percutaneous Left Atrial Appendage Occlusion: An Emerging Option in Patients with Atrial Fibrillation at High Risk of Bleeding

Atrial fibrillation (AF) is a common cardiac arrhythmia with an estimated prevalence of 1% in the general population. It is associated with an increased risk of ischemic stroke, silent cerebral ischemia, and cognitive impairment. Due to the blood flow stasis and morphology, thrombus formation occurs mainly in the left atrial appendage (LAA), particularly in the setting of nonvalvular AF (NVAF). Previous studies have shown that >90% of emboli related to NVAF originate from the LAA, thus prevention of systemic cardioembolism is indicated. According to the current guidelines, anticoagulant therapy with direct oral anticoagulants (DOACs) or vitamin K antagonists (VKAs), represents the standard of care in AF patients, in order to prevent ischemic stroke and peripheral embolization. Although these drugs are widely used and DOACs have shown, compared to VKAs, non-inferiority for stroke prevention with significantly fewer bleeding complications, some issues remain a matter of debate, including contraindications, side effects, and adherence. An increasing number of patients, indeed, because of high bleeding risk or after experiencing life-threatening bleedings, must take anticoagulants with extreme caution if not contraindicated. While surgical closure or exclusion of LAA has been historically used in patients with AF with contradictory results, in the recent years, a novel procedure has emerged to prevent the cardioembolic stroke in these patients: The percutaneous left atrial appendage occlusion (LAAO). Different devices have been developed in recent years, though not all of them are approved in Europe and some are still under clinical investigation. Currently available devices have shown a significant decrease in bleeding risk while maintaining efficacy in preventing thromboembolism. The procedure can be performed percutaneously through the femoral vein access, under general anesthesia. A transseptal puncture is required to access left atrium and is guided by transesophageal echocardiography (TEE). Evidence from the current literature indicates that percutaneous LAAO represents a safe alternative for those patients with contraindications for long-term oral anticoagulation. This review summarizes scientific evidences regarding LAAO for stroke prevention including clinical indications and an adequate patient selection.

[1]  J. Saw,et al.  Peridevice Leak Following Amplatzer Left Atrial Appendage Occlusion: Cardiac Computed Tomography Classification and Clinical Outcomes. , 2021, JACC. Cardiovascular interventions.

[2]  Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[3]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[4]  Stephen W. Zlock,et al.  Epicardial left atrial appendage occlusion with a new medical device: assessment of procedural feasibility, safety and efficacy in a large animal model , 2020, Journal of Cardiothoracic Surgery.

[5]  U. Landmesser,et al.  Left atrial appendage occlusion for stroke prevention - state of the art as provided in an updated EHRA/EAPCI consensus statement and future perspectives. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[6]  A. Camm,et al.  EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[7]  D. Delurgio,et al.  Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries. , 2019, Journal of the American College of Cardiology.

[8]  G. Cimmino,et al.  Cognitive Function and Atrial Fibrillation: From the Strength of Relationship to the Dark Side of Prevention. Is There a Contribution from Sinus Rhythm Restoration and Maintenance? , 2019, Medicina.

[9]  V. Positano,et al.  Simultaneous Functional and Morphological Assessment of Left Atrial Appendage by 3D Virtual Models , 2019, Journal of healthcare engineering.

[10]  G. Lip,et al.  The prothrombotic state in atrial fibrillation: pathophysiological and management implications , 2018, Cardiovascular Research.

[11]  Yun Gi Kim,et al.  Electrical isolation of the left atrial appendage increases the risk of ischemic stroke and transient ischemic attack regardless of postisolation flow velocity. , 2018, Heart rhythm.

[12]  E. Pokushalov,et al.  Combined atrial fibrillation ablation and left atrial appendage closure: long-term follow-up from a large multicentre registry , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  W. Shen,et al.  Left atrial appendage exclusion during mitral valve surgery and stroke in atrial fibrillation , 2018, Journal of Interventional Cardiac Electrophysiology.

[14]  T. Steiner,et al.  Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal , 2018, Journal of stroke.

[15]  K. Chun,et al.  Antithrombotic strategies after interventional left atrial appendage closure: an update , 2018, Expert review of cardiovascular therapy.

[16]  J. Camm,et al.  Left atrial appendage occlusion with the AMPLATZER Amulet device: one-year follow-up from the prospective global Amulet observational registry. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[17]  W. O’Neill,et al.  Prospective, randomized comparison of 3‐dimensional computed tomography guidance versus TEE data for left atrial appendage occlusion (PRO3DLAAO) , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[18]  Payam Safavi‐Naeini,et al.  Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status. , 2018, Texas Heart Institute journal.

[19]  Lin Liu,et al.  Evaluation of the left atrial appendage by real time three‐dimensional transesophageal echocardiography online , 2018, Echocardiography.

[20]  M. Bergmann European registry data on LAA closure: advancing the field of interventional stroke prevention. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[21]  J. Pasquié,et al.  Occurrence of Incomplete Endothelialization Causing Residual Permeability After Left Atrial Appendage Closure. , 2018, The Journal of invasive cardiology.

[22]  M. Gurol,et al.  Updates on Prevention of Cardioembolic Strokes , 2018, Journal of stroke.

[23]  Takao Kato,et al.  Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling , 2018, Scientific Reports.

[24]  Pascal Defaye,et al.  Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation. , 2018, Journal of the American College of Cardiology.

[25]  J. Saw,et al.  Incidence, Prevention, and Management of Periprocedural Complications of Left Atrial Appendage Occlusion. , 2018, Interventional cardiology clinics.

[26]  Charan T. Yerasi,et al.  An updated systematic review and meta‐analysis of early outcomes after left atrial appendage occlusion , 2018, Journal of interventional cardiology.

[27]  S. Iliceto,et al.  NOACs and atrial fibrillation: Incidence and predictors of left atrial thrombus in the real world. , 2017, International journal of cardiology.

[28]  L. Slipczuk,et al.  CT based 3D printing is superior to transesophageal echocardiography for pre-procedure planning in left atrial appendage device closure , 2017, The International Journal of Cardiovascular Imaging.

[29]  Saibal Kar,et al.  5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials. , 2017, Journal of the American College of Cardiology.

[30]  V. Guetta,et al.  Printed MDCT 3D models for prediction of left atrial appendage (LAA) occluder device size: a feasibility study. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[31]  B. Schmidt,et al.  Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[32]  W. Schillinger,et al.  Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry). , 2017, The American journal of cardiology.

[33]  J. Saw,et al.  Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug. , 2017, JACC. Cardiovascular interventions.

[34]  P. Calabrò,et al.  Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence , 2017, Therapeutic advances in drug safety.

[35]  P. Neužil,et al.  Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long‐term anticoagulation (PRAGUE‐17 study) , 2017, American heart journal.

[36]  K. Kaulback,et al.  Left Atrial Appendage Closure Device With Delivery System: A Health Technology Assessment. , 2017, Ontario health technology assessment series.

[37]  J. Brachmann,et al.  Twelve-month follow-up of left atrial appendage occlusion with Amplatzer Amulet. , 2017, Cardiology journal.

[38]  A. Dello Russo,et al.  Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[39]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[40]  L. Pérez de Isla,et al.  Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials , 2016, Heart.

[41]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[42]  Biao Xu,et al.  A meta-analysis for efficacy and safety evaluation of transcatheter left atrial appendage occlusion in patients with nonvalvular atrial fibrillation , 2016, Medicine.

[43]  K. Butcher,et al.  Novel oral anticoagulant management issues for the stroke clinician , 2016, International journal of stroke : official journal of the International Stroke Society.

[44]  L. Räber,et al.  Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices. , 2016, JACC. Cardiovascular interventions.

[45]  R. Bai,et al.  Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies. , 2016, Heart Rhythm.

[46]  U. Schotten,et al.  Novel mechanisms in the pathogenesis of atrial fibrillation: practical applications. , 2016, European heart journal.

[47]  Sergio Berti,et al.  Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[48]  P. Schulman,et al.  Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies. , 2016, Chest.

[49]  H. Kamel,et al.  Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model , 2016, Stroke.

[50]  B. Meier,et al.  Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[51]  S. Kische,et al.  Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry , 2016, European heart journal.

[52]  M. Price,et al.  Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin: A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience. , 2015, JACC. Cardiovascular interventions.

[53]  P. Mclaughlin,et al.  Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure. , 2015, European heart journal cardiovascular Imaging.

[54]  S. Asirvatham,et al.  A Review Of The Relevant Embryology, Pathohistology, And Anatomy Of The Left Atrial Appendage For The Invasive Cardiac Electrophysiologist. , 2015, Journal of atrial fibrillation.

[55]  Saibal Kar,et al.  Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. , 2015, Journal of the American College of Cardiology.

[56]  Siew Yen Ho,et al.  Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography. , 2015, JACC. Cardiovascular imaging.

[57]  P. Wenaweser,et al.  Early results of first versus second generation Amplatzer occluders for left atrial appendage closure in patients with atrial fibrillation , 2015, Clinical Research in Cardiology.

[58]  N. Patel,et al.  Left atrial appendage occlusion for prevention of stroke in nonvalvular atrial fibrillation: a meta-analysis , 2015, Journal of Interventional Cardiac Electrophysiology.

[59]  M. Price,et al.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. , 2014, Journal of the American College of Cardiology.

[60]  Ioanna Kougioumtzi,et al.  Left atrial appendage exclusion-Where do we stand? , 2014, Journal of thoracic disease.

[61]  Soidjon Khodjaev Md,et al.  Retrospective Evaluation Of Novel Percutaneous Left Atrial Appendage Ligation Using The LARIAT Suturing Device: Single Center Initial Experience. , 2014, Journal of atrial fibrillation.

[62]  V. Martin-Yuste,et al.  Percutaneous left atrial appendage occlusion. , 2013, Revista espanola de cardiologia.

[63]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[64]  Frederick T. Han,et al.  Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. , 2013, Journal of the American College of Cardiology.

[65]  D. Singer,et al.  Risks and Benefits of Anticoagulation in Atrial Fibrillation: Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry , 2013, Circulation. Cardiovascular quality and outcomes.

[66]  R. Mahajan,et al.  Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure , 2012, Heart.

[67]  A. Natale,et al.  [New technology for prevention of embolic events in atrial fibrillation: a systematic review on percutaneous endovascular left atrial appendage closure]. , 2012, Giornale italiano di cardiologia.

[68]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[69]  Angelo Auricchio,et al.  Evaluation of the Left Atrial Appendage With Real-Time 3-Dimensional Transesophageal Echocardiography: Implications for Catheter-Based Left Atrial Appendage Closure , 2011, Circulation. Cardiovascular imaging.

[70]  R. Troughton,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[71]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[72]  Maurice Buchbinder,et al.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2009, The Lancet.

[73]  Timothy Watson,et al.  Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited , 2009, The Lancet.

[74]  Bohn Stafleu van Loghum,et al.  Online … , 2002, LOG IN.

[75]  M. Lesh,et al.  Percutaneous Left Atrial Appendage Transcatheter Occlusion to Prevent Stroke in High-Risk Patients With Atrial Fibrillation: Early Clinical Experience , 2002, Circulation.

[76]  A. Camm,et al.  Left atrial appendage: structure, function, and role in thromboembolism , 1999, Heart.

[77]  J. Odell,et al.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.

[78]  J. Greenfield,et al.  Compliance of left atrium with and without left atrium appendage. , 1990, The American journal of physiology.

[79]  H. Aberg Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. , 2009, Acta medica Scandinavica.